Notice Number: NOT-GM-19-040
Key Dates
Release Date: May 1, 2019
PAR-19-254
PAR-19-253
Issued by
National Institute of General Medical Sciences (NIGMS)
Purpose
The purpose of this Notice is to inform potential applicants to the NIGMS Technology Development R21 (PAR-19-254) and R01 (PAR-19-253) funding opportunity announcements (FOAs) of an upcoming webinar on planning submissions to this program. Participation in the webinar, although encouraged, is optional and is not required for application submission.
Background
The NIGMS technology development FOAs support two stages of technology development: Stage 1 from concept to proof of concept (R21) and Stage 2 from feasibility to working prototype (R01).
The technology development FOAs encourage evaluation of technological hypotheses without the pressure to additionally test unknown biological questions. Technologies might originate from biomedical disciplines or from engineering and the physical sciences. Examples include instruments, devices, processes, algorithms, software, chemicals, biomolecules, or cells that have potential value for generating new basic biomedical research. Applications submitted to these FOAs that include untested biological hypotheses will not be funded. Validation studies are appropriate for these FOAs, and descriptions of the future biological utility to research within the mission of NIGMS are strongly recommended.
Webinar Information
During this webinar, NIGMS staff will discuss areas of science within the NIGMS mission, the process by which applications will be assessed for fit to the program, and key review criteria that should be kept in mind during application preparation.
Topic: NIGMS Technology Development Webinar
Time: May 14, 2019 3:00 - 4:00 PM Eastern Time (US and Canada)
Password: NIGMS
Meeting ID: 376 708 758
One tap mobile
+16465588656,,376708758# US (New York)
+16699006833,,376708758# US (San Jose)
Dial by your location
+1 646 558 8656 US (New York)
+1 669 900 6833 US (San Jose)
877 369 0926 US Toll-free
877 853 5247 US Toll-free
Slides will be posted on the Technology development website.
Questions can be submitted in advance or during the webinar to: [email protected].
Inquiries
Please direct all inquiries to:
Paul Sammak, Ph.D.
Division of Biomedical Technology, Bioinformatics, and Computational Biosciences
National Institute of General Medical Sciences (NIGMS)
or
Miles Fabian, Ph.D.
Division of Pharmacology, Physiology, and Biological Chemistry
National Institute of General Medical Sciences (NIGMS)
at:
[email protected]
and Human Services (HHS)
